Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Peptic Ulcer

Free Subscription Articles published in Gut Retrieve available abstracts of 40 articles: HTML format Text format

Single Articles

August 2019
1. XIAO Y, Zhang S, Dai N, Fei G, et al
   Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.
   Gut. 2019 Aug 13. pii: gutjnl-2019-318365. doi: 10.1136/gutjnl-2019-318365.
   PubMed     Text format     Abstract available
   
   
   May 2019
2. DOORAKKERS E, Lagergren J, Engstrand L, Brusselaers N, et al
   Reply to: Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a western population.
   Gut. 2019 May 21. pii: gutjnl-2019-319000. doi: 10.1136/gutjnl-2019-319000.
   PubMed     Text format    
   
   
   
3. GUO CG, Cheung KS, Zhang F, Chan EW, et al
   Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for Helicobacter pylori: a territory-wide cohort study.
   Gut. 2019 May 17. pii: gutjnl-2019-318352. doi: 10.1136/gutjnl-2019-318352.
   PubMed     Text format     Abstract available
   
   
   February 2019
4. 
   Correction: Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018.
   Gut. 2019;68:380.
   PubMed     Text format    
   
   
   September 2018
5. CHOI E, Lantz TL, Vlacich G, Keeley TM, et al
   Lrig1+ gastric isthmal progenitor cells restore normal gastric lineage cells during damage recovery in adult mouse stomach.
   Gut. 2018;67:1595-1605.
   PubMed     Text format     Abstract available
   
   
   July 2018
6. CHUANG SC, Lin CC, Peng CY, Huang WH, et al
   Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study.
   Gut. 2018 Jul 17. pii: gutjnl-2018-316899. doi: 10.1136/gutjnl-2018-316899.
   PubMed     Text format    
   
   
   
7. MOAYYEDI P, Veldhuyzen van Zanten SJO, Hookey L, Armstrong D, et al
   Proton pump inhibitors and gastric cancer: association is not causation.
   Gut. 2018 Jul 13. pii: gutjnl-2018-316958. doi: 10.1136/gutjnl-2018-316958.
   PubMed     Text format    
   
   
   
8. LOFFROY R, Bardou M
   Prophylactic angiographic embolisation in high-risk peptic ulcer bleeding after achieved endoscopic control: maximising outcomes.
   Gut. 2018 Jul 11. pii: gutjnl-2018-316925. doi: 10.1136/gutjnl-2018-316925.
   PubMed     Text format    
   
   
   
9. POTTER MDE, Wood NK, Walker MM, Jones MP, et al
   Proton pump inhibitors and suppression of duodenal eosinophilia in functional dyspepsia.
   Gut. 2018 Jul 7. pii: gutjnl-2018-316878. doi: 10.1136/gutjnl-2018-316878.
   PubMed     Text format    
   
   
   June 2018
10. KAWAI T, Oda K, Funao N, Nishimura A, et al
    Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study.
    Gut. 2018;67:1033-1041.
    PubMed     Text format     Abstract available
    
    
    May 2018
11. KOBAYASHI J, Uchida H, Ito J
    Long-term proton pump inhibitor use after Helicobacter pylori eradication may create a gastric environment for N-nitrosamine formation and gastric cancer development.
    Gut. 2018 May 25. pii: gutjnl-2018-316592. doi: 10.1136/gutjnl-2018-316592.
    PubMed     Text format    
    
    
    
12. LAU JYW, Pittayanon R, Wong KT, Pinjaroen N, et al
    Prophylactic angiographic embolisation after endoscopic control of bleeding to high-risk peptic ulcers: a randomised controlled trial.
    Gut. 2018 May 25. pii: gutjnl-2018-316074. doi: 10.1136/gutjnl-2018-316074.
    PubMed     Text format     Abstract available
    
    
    April 2018
13. SUNG JJ, Chiu PC, Chan FKL, Lau JY, et al
    Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018.
    Gut. 2018 Apr 24. pii: gutjnl-2018-316276. doi: 10.1136/gutjnl-2018-316276.
    PubMed     Text format     Abstract available
    
    
    
14. LAI SW, Lai HC, Lin CL, Liao KF, et al
    Proton pump inhibitors and risk of gastric cancer in a case-control study.
    Gut. 2018 Apr 16. pii: gutjnl-2018-316371. doi: 10.1136/gutjnl-2018-316371.
    PubMed     Text format    
    
    
    
15. WAN QY, Wu XT, Li N, Du L, et al
    Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926 386 participants.
    Gut. 2018 Apr 3. pii: gutjnl-2018-316416. doi: 10.1136/gutjnl-2018-316416.
    PubMed     Text format    
    
    
    February 2018
16. PENG YC, Huang LR, Lin CL, Hsu WY, et al
    Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.
    Gut. 2018 Feb 22. pii: gutjnl-2018-316057. doi: 10.1136/gutjnl-2018-316057.
    PubMed     Text format    
    
    
    January 2018
17. DOORAKKERS E, Lagergren J, Engstrand L, Brusselaers N, et al
    Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population.
    Gut. 2018 Jan 30. pii: gutjnl-2017-315363. doi: 10.1136/gutjnl-2017-315363.
    PubMed     Text format     Abstract available
    
    
    
18. SUISSA S, Suissa A
    Proton-pump inhibitors and increased gastric cancer risk: time-related biases.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315729. doi: 10.1136/gutjnl-2017-315729.
    PubMed     Text format    
    
    
    December 2017
19. NIIKURA R, Hayakawa Y, Hirata Y, Yamada A, et al
    Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis.
    Gut. 2017 Dec 22. pii: gutjnl-2017-315710. doi: 10.1136/gutjnl-2017-315710.
    PubMed     Text format    
    
    
    
20. SUZUKI H, Matsuzaki J
    Helicobacter pylori eradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk.
    Gut. 2017 Dec 15. pii: gutjnl-2017-315698. doi: 10.1136/gutjnl-2017-315698.
    PubMed     Text format    
    
    
    November 2017
21. GUETA I, Halkin H, Markovits N, Loebstein R, et al
    Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B 12.
    Gut. 2017 Nov 28. pii: gutjnl-2017-315695. doi: 10.1136/gutjnl-2017-315695.
    PubMed     Text format    
    
    
    
22. WALDUM HL, Fossmark R
    Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man.
    Gut. 2017 Nov 20. pii: gutjnl-2017-315629. doi: 10.1136/gutjnl-2017-315629.
    PubMed     Text format    
    
    
    October 2017
23. CHEUNG KS, Chan EW, Wong AYS, Chen L, et al
    Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study.
    Gut. 2017 Oct 31. pii: gutjnl-2017-314605. doi: 10.1136/gutjnl-2017-314605.
    PubMed     Text format     Abstract available
    
    
    
24. REVELES KR, Ryan CN, Chan L, Cosimi RA, et al
    Proton pump inhibitor use associated with changes in gut microbiota composition.
    Gut. 2017 Oct 9. pii: gutjnl-2017-315306. doi: 10.1136/gutjnl-2017-315306.
    PubMed     Text format    
    
    
    
25. MIZOKAMI Y, Oda K, Funao N, Nishimura A, et al
    Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study.
    Gut. 2017 Oct 7. pii: gutjnl-2017-314010. doi: 10.1136/gutjnl-2017-314010.
    PubMed     Text format     Abstract available
    
    
    September 2017
26. GRAHAM DY
    Illusions regarding Helicobacter pylori clinical trials and treatment guidelines.
    Gut. 2017 Sep 21. pii: gutjnl-2017-314744. doi: 10.1136/gutjnl-2017-314744.
    PubMed     Text format    
    
    
    
27. NOTO JM, Chopra A, Loh JT, Romero-Gallo J, et al
    Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments.
    Gut. 2017 Sep 18. pii: gutjnl-2017-313863. doi: 10.1136/gutjnl-2017-313863.
    PubMed     Text format     Abstract available
    
    
    
28. HUO X, Agoston AT, Dunbar KB, Cipher DJ, et al
    Hypoxia-inducible factor-2alpha plays a role in mediating oesophagitis in GORD.
    Gut. 2017;66:1542-1554.
    PubMed     Text format     Abstract available
    
    
    August 2017
29. VOHLONEN IJ, Hakama M, Harkonen M, Malila N, et al
    Oesophageal cancer incidence in 20-year follow-up in a population-based sample of 12 000 middle-age men with or without Helicobacter pylori infection in Finland.
    Gut. 2017 Aug 31. pii: gutjnl-2017-314913. doi: 10.1136/gutjnl-2017-314913.
    PubMed     Text format    
    
    
    June 2017
30. MERA RM, Bravo LE, Camargo MC, Bravo JC, et al
    Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial.
    Gut. 2017 Jun 24. pii: gutjnl-2016-311685. doi: 10.1136/gutjnl-2016-311685.
    PubMed     Text format     Abstract available
    
    
    
31. LIN PY, Tang JH, Chang CC
    A rare cause of GI bleeding in a 56-year-old man.
    Gut. 2017;66:1074.
    PubMed     Text format    
    
    
    May 2017
32. SIERRA JC, Asim M, Verriere TG, Piazuelo MB, et al
    Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.
    Gut. 2017 May 4. pii: gutjnl-2016-312888. doi: 10.1136/gutjnl-2016-312888.
    PubMed     Text format     Abstract available
    
    
    April 2017
33. HOUGHTON LA, Smith JA
    Gastro-oesophageal reflux events: just another trigger in chronic cough?
    Gut. 2017 Apr 25. pii: gutjnl-2017-314027. doi: 10.1136/gutjnl-2017-314027.
    PubMed     Text format    
    
    
    
34. LORD AR, Simms LA, Hanigan K, Sullivan R, et al
    Protective effects of Helicobacter pylori for IBD are related to the cagA-positive strain.
    Gut. 2017 Apr 13. pii: gutjnl-2017-313805. doi: 10.1136/gutjnl-2017-313805.
    PubMed     Text format    
    
    
    February 2017
35. EUSEBI LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, et al
    Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis.
    Gut. 2017 Feb 23. pii: gutjnl-2016-313589. doi: 10.1136/gutjnl-2016-313589.
    PubMed     Text format     Abstract available
    
    
    December 2016
36. OTSUKA T, Sugimoto M, Inoue R, Ohno M, et al
    Influence of potassium-competitive acid blocker on the gut microbiome of Helicobacter pylori-negative healthy individuals.
    Gut. 2016 Dec 13. pii: gutjnl-2016-313312. doi: 10.1136/gutjnl-2016-313312.
    PubMed     Text format    
    
    
    October 2016
37. MERCHANT JL
    NF-kappaB mediated transcription of DARPP-32 prevents Helicobacter pylori-induced cell death.
    Gut. 2016 Oct 27. pii: gutjnl-2016-312822. doi: 10.1136/gutjnl-2016-312822.
    PubMed     Text format    
    
    
    
38. MALFERTHEINER P, Megraud F, O'Morain CA, Gisbert JP, et al
    Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
    Gut. 2016 Oct 5. pii: gutjnl-2016-312288. doi: 10.1136/gutjnl-2016-312288.
    PubMed     Text format     Abstract available
    
    
    September 2016
39. YEO YH, Shiu SI, Ho HJ, Zou B, et al
    First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis.
    Gut. 2016 Sep 26. pii: gutjnl-2016-311868. doi: 10.1136/gutjnl-2016-311868.
    PubMed     Text format     Abstract available
    
    
    
40. MOLINA-INFANTE J, Hirano I, Spechler SJ
    Clarifying misunderstandings and misinterpretations about proton pump inhibitor-responsive oesophageal eosinophilia.
    Gut. 2016 Sep 13. pii: gutjnl-2016-312851. doi: 10.1136/gutjnl-2016-312851.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Peptic Ulcer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: